Skip to content

62d0afa500000132 Gluconeogenesis 2 Mouse

Now I'll provide a comprehensive review of the GO-CAM model "Gluconeogenesis 2 (Mouse)" (gomodel:62d0afa500000132).

GO-CAM Review: Gluconeogenesis 2 (Mouse) (gomodel:62d0afa500000132)

Summary

This GO-CAM model represents the mouse gluconeogenesis pathway, showing the enzymatic steps involved in the synthesis of glucose from non-carbohydrate precursors. The model includes 14 activities performed by different mouse gene products, with appropriate subcellular localizations and causal relationships following the metabolic flow of the pathway.

Strengths

  1. Comprehensive pathway representation: The model captures all major enzymatic steps of gluconeogenesis, including both mitochondrial and cytosolic phases of the pathway.

  2. Proper causal connections: The activities are correctly connected via "provides input for" (RO:0002413) relationships that accurately follow the substrate flow through the pathway.

  3. Appropriate subcellular localization: Activities are correctly localized to relevant cellular compartments (cytosol, ER, mitochondria), which is essential for representing gluconeogenesis properly.

  4. Evidence quality: Each activity is supported by specific evidence in the form of PMIDs, with appropriate evidence codes (ECO:0000314 - direct assay, ECO:0000315 - mutant phenotype, etc.).

  5. Taxonomic specificity: The model appropriately represents the mouse (MGI) proteins, providing a species-specific representation of gluconeogenesis.

Areas for Improvement

  1. Incomplete causal chain: There is a missing causal link between phosphoenolpyruvate carboxykinase (Pck2, gomodel:62d0afa500000132/62d0afa500000206) and enolase (Eno1, gomodel:62d0afa500000132/62d0afa500000148). This breaks the continuity of the pathway flow.

  2. Branching missing for G6pc3: While both G6pc1 and G6pc3 (glucose-6-phosphatase isoforms) are represented in the model, G6pc3 (gomodel:62d0afa500000132/62f58d8800003972) lacks outgoing causal connections, making its role in the pathway unclear. It should either connect to the next step or be noted as an endpoint.

  3. Regulatory elements: The model focuses on the catalytic flow of gluconeogenesis but does not include regulatory elements that control the pathway. Including key regulatory interactions (e.g., glucagon or insulin signaling) would enhance the biological completeness.

  4. Substrate visualization: While the causal flow is represented correctly, the model doesn't explicitly show the substrate transformations. Adding annotations about the metabolites being processed at each step would improve clarity.

  5. Tissue context: Gluconeogenesis predominantly occurs in the liver and kidney in mammals. Adding tissue context information would enhance the biological relevance of the model.

Scientific Validity

The literature evidence provided in the model supports the represented activities:

  1. The UniProt entry for G6pc1 (P35576) confirms its role in glucose-6-phosphate hydrolysis in the ER, consistent with its representation in the model.

  2. The reference PMID:24958256 confirms the importance of gluconeogenesis in metabolic regulation and mentions several of the enzymes included in the model.

  3. The subcellular localizations are consistent with known biology - mitochondrial enzymes (Pcx, Pck2) are correctly placed in the mitochondrial matrix, while cytosolic enzymes are in the cytosol.

Pathway Logic and Flow

The overall flow of gluconeogenesis is correctly represented:

  1. Mitochondrial initiation: Starting with pyruvate carboxylase (Pcx) converting pyruvate to oxaloacetate in the mitochondria.

  2. Mitochondrial to cytosolic transition: Phosphoenolpyruvate carboxykinase (Pck2) converting oxaloacetate to phosphoenolpyruvate.

  3. Cytosolic reversed glycolysis: The cytosolic enzymes (Eno1 → Pgam1 → Pgk1 → Gapdh → Tpi1 → Aldoc) performing essentially glycolysis in reverse.

  4. Final glucose production steps: The final steps (Fbp1 → Gpi1 → G6pc1/G6pc3 and Slc37a4) correctly represent the production and transport of glucose.

Recommendations for Improvement

  1. Add missing causal link: Connect Pck2 to Eno1 to complete the pathway flow.

  2. Clarify G6pc3 role: Either connect G6pc3 to downstream processes or annotate it as an endpoint with notes on its specific role.

  3. Include regulation: Add key regulatory interactions, such as how insulin inhibits gluconeogenesis or how glucagon activates it.

  4. Add tissue context: Specify the tissue context (liver/kidney) where this pathway predominantly functions.

  5. Consider adding complexes: Some enzymes may function as complexes; using GO guidelines for complex representation would enhance model accuracy.

  6. Substrate annotation: Consider adding annotations about the intermediates being processed at each enzymatic step for increased clarity.

Conclusion

Overall, this GO-CAM model provides a good representation of the gluconeogenesis pathway in mouse, with appropriate gene products, subcellular localizations, and mostly correct causal flow. The model strongly adheres to GO-CAM best practices but would benefit from addressing the gaps in causal connections and adding regulatory elements. With these improvements, the model would provide a more complete picture of gluconeogenesis and its regulation in the mouse.